BVF »

Nektar Therapeutics shares owned by BVF

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by BVF from 13F filings

Historical chart of BVF investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by BVF

Quarter filed Position value Share count Share price at filing
2025-09-30 $73M 1.3M 56.90

More positions owned by BVF

Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Cidara Therapeutics Com New (CDTX)
Gh Research Ordinary Shares (GHRS)
Mirum Pharmaceuticals (MIRM)
Xoma Royalty Corporation Com New (XOMA)
Structure Therapeutics Sponsored Ads (GPCR)
Kura Oncology (KURA)
Septerna (SEPN)
Palvella Therapeutics Inc Ne (PVLA)
Nektar Therapeutics Com New (NKTR)
Zymeworks Del (ZYME)
Axsome Therapeutics (AXSM)

View all positions for BVF

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics